Consistently with this finding and the results of loss-of-function studies in mice [42], STAT1 expression is often lost in human breast cancer biopsies and STAT1 has been discussed as a predictive marker for breast cancer therapy [25], [43]. This evidence concerns the gene STAT1 and breast carcinoma.